A total of 154 TET2 mutations were seen in 94 cases of AITL and PTCL‐FTH, and 118 (77%) of these mutations were frameshift indels or nonsense changes, and rather widely distributed, predicting variably truncated protein products (supplementary material, Figure S1). This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.